JD Supra January 11, 2022
As the 117th Congress moves into its second legislative session, there is no shortage of health care policy issues dotting the landscape. The COVID-19 pandemic, legislative gridlock and a 2021 that was largely locked down by ongoing negotiations around the infrastructure and Build Back Better packages have left a range of stakeholders looking and hoping for actions on priorities that have been stalled in this climate. Congress has now mostly confirmed President Biden’s administration leaders across the Department of Health and Human Services and other health-related agencies, with the notable exception of Dr. Robert Califf, who is expected to be confirmed as Food and Drug Administration (FDA) Commissioner early this year and whose nomination will be voted on by the...
Today's Sponsors
Today's Sponsor